Homocysteine and antiphospholipid antibodies in rheumatoid arthritis patients: Relationships with thrombotic events

Clinical and Experimental Rheumatology

Volumn 19, Issue 5, 2001, Pages 561-564

  Seriolo, B ^a   Fasciolo, D ^a   Sulli, A ^a   Cutolo, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Antiphospholipid antibodies; Homocysteine; Rheumatoid arthritis; Thrombotic events

Indexed keywords

CARDIOLIPIN ANTIBODY; HOMOCYSTEINE; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ADULT; AGE; AMINO ACID BLOOD LEVEL; ARTERY THROMBOSIS; ARTICLE; CLINICAL OBSERVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; ITALY; MAJOR CLINICAL STUDY; MORTALITY; OUTPATIENT DEPARTMENT; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; STATISTICAL ANALYSIS; THROMBOSIS; UNIVERSITY; VASCULAR DISEASE; VEIN THROMBOSIS;

ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTIPHOSPHOLIPID; ARTHRITIS, RHEUMATOID; FEMALE; HOMOCYSTEINE; HUMANS; LUPUS COAGULATION INHIBITOR; MIDDLE AGED; RISK FACTORS; THROMBOSIS;

EID: 0034820518     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. The significance of vascular inflammation in rheumatoid arthritis
2. Lipoproteins, anticardiolipin antibodies and thrombotic events in rheumatoid arthritis
3. Vasculitis and antiphospholipid syndrome
4. Hyperhomocysteinemia and venous thrombosis: A meta-analysis
5. Prevalence of congenital homocystinuria in Denmark
6. Vitamin B12, vitamin B6, and folate nutritional status in men with hyperhomocysteinemia
7. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
8. Measurement of homocyst(e)ine in the prediction of arteriosclerosis
9. Blood levels of homocysteine and increased risk of cardiovascular disease. Causal or casual?
10. Plasma total homocysteine levels in hyperthyroid and hypothiroid patients
11. High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: A pathogenic link with thromboembolic complications?
12. Urinary excretion of pyridoxine and 4-pyridoxic acid in rheumatoid arthritis
13. Factor V Arg506 → Gln mutation in patients with antiphosphiolipid antibodies
14. The impact of the search for thrombophilia risk factors among antiphospholipid syndrome patients with thrombosis
15. Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: A retrospective cohort study
16. The mortality of rheumatoid arthritis